SCD and cancer: These data demonstrate that ADAR1-mediated RNA-editing upregulates SCD1 protein abundance, thereby facilitating lipid droplet formation and β-catenin stability to confer chemoresistance and cancer stemness, leading to survival under chemotherapy-induced stress.